Walter & Keenan Financial Consulting Co. MI ADV held its stake in Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,225 shares of the company’s stock at the close of the 2nd quarter. Walter & Keenan Financial Consulting Co. MI ADV’s holdings in Colgate-Palmolive were worth $1,870,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive in the 1st quarter worth about $102,000. Proficio Capital Partners LLC lifted its stake in shares of Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after purchasing an additional 207 shares in the last quarter. OLD Second National Bank of Aurora acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at about $109,000. Harbour Capital Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at about $121,000. Finally, Hanson & Doremus Investment Management lifted its stake in shares of Colgate-Palmolive by 4.5% in the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after purchasing an additional 70 shares in the last quarter. 73.09% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Colgate-Palmolive Company (CL) opened at 72.90 on Wednesday. The company’s 50 day moving average price is $72.06 and its 200 day moving average price is $73.15. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The stock has a market capitalization of $64.21 billion, a P/E ratio of 27.09 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.72. The company had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm’s revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.70 EPS. On average, equities analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.
CL has been the topic of several research analyst reports. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a research note on Tuesday, July 4th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Macquarie initiated coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price objective on the stock. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. Finally, BidaskClub lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $76.31.
TRADEMARK VIOLATION NOTICE: This article was first reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.com-unik.info/2017/10/11/colgate-palmolive-company-cl-stake-held-by-walter-keenan-financial-consulting-co-mi-adv.html.
In other news, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $72.41, for a total transaction of $277,547.53. Following the completion of the sale, the insider now owns 53,022 shares in the company, valued at approximately $3,839,323.02. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Dennis J. Hickey sold 73,872 shares of the company’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the sale, the chief financial officer now owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The disclosure for this sale can be found here. In the last quarter, insiders have sold 217,969 shares of company stock valued at $15,693,933. 1.02% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
What are top analysts saying about Colgate-Palmolive Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive Company and related companies.